About 10 million people in the United States suffer from fibromyalgia, a syndrome characterized by chronic widespread pain, sleep disturbances, fatigue and, often, psychological distress as a result. Of them, about 75-90 percent are women, according to the National Fibromyalgia Association (NFA).
Because people with fibromyalgia often “test” healthy according to typical medical diagnostic procedures, it takes an average of five years for a person to be correctly diagnosed. There are currently no laboratory tests that can detect it, so doctors rely on patient symptoms, medical histories and a “manual tender point” examination.
If a person experiences widespread pain in the body’s four quadrants for three months or more, along with tenderness or pain in 11 of 18 specific “tender” points upon pressure, a diagnosis of fibromyalgia is typically given. There is also a new set of criteria — a “widespread pain index” that also measures symptom severity — that the American College of Rheumatology recently approved as an effective new diagnostic tool.
For many years, people were told by their doctors that fibromyalgia was all in their heads, but with recent advances the medical community is beginning to accept the syndrome as a real medical condition … one that demands safe and effective treatment.